The study of mitochondrial A3243G mutation in different samples

Area of Science:

• Genetics
• Neurology
• Mitochondrial Diseases

Background:

• Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is frequently caused by the A3243G mutation in mitochondrial DNA.
• Blood testing for the A3243G mutation has limitations in diagnosing MELAS and its carriers, with poor correlation to disease severity.

Purpose of the Study:

• To compare the A3243G mutation ratio in blood, urine, hair follicles, and saliva from MELAS patients and maternal relatives.
• To identify optimal sample types for MELAS diagnosis and carrier detection.
• To evaluate the utility of mutation ratios in different tissues for assessing clinical severity.

Main Methods:

• Analysis of A3243G mutation ratios in blood, urine, hair follicles, and saliva.
• Study involved 32 families with MELAS patients and maternal relatives.
• Correlation analysis between mutation ratios and clinical phenotypes.

Main Results:

• The A3243G mutation ratio was significantly higher in urine than in blood for MELAS patients and carriers with mild or no symptoms.
• A strong correlation was observed between A3243G mutation ratios across blood, urine, hair follicles, and saliva in probands and relatives.
• Clinical features of MELAS showed a close correlation with the mutation ratio in urine.

Conclusions:

• Urine analysis for the A3243G mutation is a non-invasive, convenient, and rapid diagnostic method for MELAS.
• Urine testing provides superior diagnostic value compared to blood testing for MELAS and carrier assessment.
• Urine mutation ratio is a useful indicator for evaluating MELAS clinical severity.